Neeltje Steeghs
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 40
-
- Lung Cancer Treatments and Mutations 41
- Sarcoma Diagnosis and Treatment 37
- Gastric Cancer Management and Outcomes 30
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 33
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 30
- Genetics top 2%
-
- Gastrointestinal Tumor Research and Treatment 42
-
- PI3K/AKT/mTOR signaling in cancer 24
- Co-authors
- Jos H. BeijnenAlwin D. R. HuitemaJan H.M. SchellensHans GelderblomRemy B. VerheijenHuixin YuKimberley M. HeinhuisMartijn P. Lolkema
- Journals
- Nature Communications (2 papers)Nature Genetics (2 papers)Journal of Clinical Oncology (40 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Neeltje Steeghs
232 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 1.9k
- Cancer Research 857
- Hematology 635
- Genetics 597
Countries citing papers authored by Neeltje Steeghs
This map shows the geographic impact of Neeltje Steeghs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neeltje Steeghs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neeltje Steeghs more than expected).
Fields of papers citing papers by Neeltje Steeghs
This network shows the impact of papers produced by Neeltje Steeghs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neeltje Steeghs. The network helps show where Neeltje Steeghs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Neeltje Steeghs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 1 | |
| 11 | Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Studybreakdown → | 2021 | 331 |
| 12 | 2021 | 10 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 45 | |
| 16 | 2021 | 2 | |
| 17 | 2020 | 39 | |
| 18 | 2020 | 41 | |
| 19 | 2019 | 58 | |
| 20 | 2018 | 13 |
About Neeltje Steeghs
Neeltje Steeghs is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 242 papers that have together received 5.4k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (42 papers), Lung Cancer Treatments and Mutations (41 papers), Colorectal Cancer Treatments and Studies (40 papers), Sarcoma Diagnosis and Treatment (37 papers), Cancer Genomics and Diagnostics (33 papers), Gastric Cancer Management and Outcomes (30 papers), Chronic Myeloid Leukemia Treatments (30 papers) and PI3K/AKT/mTOR signaling in cancer (24 papers). The work is most often cited by research in Oncology (2.8k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Cancer Research (857 citations). Neeltje Steeghs has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Jan H.M. Schellens, Hans Gelderblom, Remy B. Verheijen, Huixin Yu, Kimberley M. Heinhuis, Martijn P. Lolkema, Willeke Ros and Marleen Kok. Their work appears in journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.